Earnings Summary

Rhythm Pharmaceuticals Inc’s revenue jumped 51.28% since last year same period to $29.08Mn in the Q2 2024. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 11.98% jump in its revenue since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit jumped 30.92% since last year same period to $-32.26Mn in the Q2 2024. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 77.18% jump in its net profits since last 3-months.

Rhythm Pharmaceuticals Inc’s net profit margin jumped 54.34% since last year same period to -110.95% in the Q2 2024. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 79.62% jump in its net profit margins since last 3-months.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -2.16.

Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 15.85% since last year same period to -0.69 in the Q2 2024. This indicates that the Rhythm Pharmaceuticals Inc has generated 15.85% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Rhythm Pharmaceuticals Inc’s return on assets (ROA) stands at -0.48.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Rhythm Pharmaceuticals Inc’s return on equity (ROE) stands at -1.43.